Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere Health Condition 2: G610- Guillain-Barre syndrome
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Diagnosis of GBS confirmed by diagnostic criteria for GBS of the National Institute of Neurological Disorders and Stroke (NINDS) or one of the variants of GBS, including the MFS and overlap syndromes 2. Hospital admission within 4 - weeks of the onset of weakness (or other symptoms attributed to GBS.
Exclusion criteria
Exclusion criteria: 1. Subacute Inflammatory demyelinating neuropathy (SIDP) 2. Toxic neuropathies 3. Vasculitic neuropathies
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Proportion of patients with GBS admitted during COVID pandemic compared to similar period in the previous yearTimepoint: 7 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Demographic characteristics of GBS patientsTimepoint: 7 months;Proportion of GBS patients requiring invasive ventilationTimepoint: 7 months;Proportion of GBS patients who received IVIGTimepoint: 7 months;Proportion of GBS patients who received Plasma exchangeTimepoint: 7 months | — |
Countries
India
Contacts
AIIMS New Delhi